Mylan Secures Approval For Distribution Of Its Remdesivir Injection

The pharmaceutical company Mylan announced that it has secured Indian approval for its remdesivir injection for restricted emergency use for COVID-19 patients. Mylan will sell the drug under the brand name DESREM and will be priced at Rs 4,800.